Literature DB >> 35064060

Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors.

Theresa A Hastert1,2, Julie J Ruterbusch1,2, Judith Abrams1,2, Mrudula Nair1,2, Angie S Wenzlaff1,2, Jennifer L Beebe-Dimmer1,2, Stephanie S Pandolfi1,2, Ann G Schwartz1,2.   

Abstract

BACKGROUND: Financial hardship is most common among cancer survivors with the fewest financial resources at diagnosis; however, little is known about the financial outcomes of young adult (YA) survivors (ages 20-39 at diagnosis), despite their having fewer financial reserves than older adults.
METHODS: We utilized data from 3,888 participants in the population-based Detroit Research on Cancer Survivors cohort. Participants self-reported several forms of material and behavioral financial hardship (MFH and BFH, respectively). Psychological financial hardship (PFH) was measured using the Comprehensive Score for financial Toxicity (COST) score. Modified Poisson models estimated prevalence ratios (PR) and 95% confidence intervals (CI) for financial hardship by age at diagnosis controlling for demographic, socioeconomic, and cancer-related factors.
RESULTS: MFH prevalence was inversely associated with age such that 72% of YA survivors reported MFH, 62% ages 40 to 54, 49% ages 55 to 64, and 33% ages 65 to 79 (PRadjusted YA vs. 65+: 1.75; 95% CI, 1.49-2.04; Ptrend < 0.001). BFH was also more common among YA survivors (26%) than those ages 65 to 79 (20%; PRadjusted: 1.50; 95% CI, 1.08-2.08; Ptrend = 0.019). Age was positively associated with financial wellbeing. COST scores ranged from 20.7 (95% CI, 19.0-22.4) among YA survivors to 27.2 (95% CI, 26.1-28.2) among adults 65 to 79 years old (Ptrend < 0.001).
CONCLUSIONS: In this population of African American cancer survivors, MFH and BFH were more common, and PFH was more severe, in YA survivors compared with those diagnosed as older adults. IMPACT: Young adulthood at diagnosis should be considered a risk factor for cancer-related financial hardship and addressed in work designed to reduce the adverse financial impacts of cancer. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35064060      PMCID: PMC9377160          DOI: 10.1158/1055-9965.EPI-21-0739

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  30 in total

1.  Standardized binomial models for risk or prevalence ratios and differences.

Authors:  David B Richardson; Alan C Kinlaw; Richard F MacLehose; Stephen R Cole
Journal:  Int J Epidemiol       Date:  2015-07-30       Impact factor: 7.196

2.  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.

Authors:  Jonas A de Souza; Bonnie J Yap; Fay J Hlubocky; Kristen Wroblewski; Mark J Ratain; David Cella; Christopher K Daugherty
Journal:  Cancer       Date:  2014-06-20       Impact factor: 6.860

3.  Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors.

Authors:  Jean A McDougall; Matthew P Banegas; Charles L Wiggins; Vi K Chiu; Ashwani Rajput; Anita Y Kinney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-28       Impact factor: 4.254

4.  Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress.

Authors:  Ryan D Nipp; Leah L Zullig; Gregory Samsa; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy P Abernethy; S Yousuf Zafar
Journal:  Psychooncology       Date:  2015-07-07       Impact factor: 3.894

5.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

Authors:  Veena Shankaran; Sanjay Jolly; David Blough; Scott D Ramsey
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

6.  Cost-related medication nonadherence among adolescent and young adult cancer survivors.

Authors:  Sapna Kaul; Jaqueline C Avila; Hemalkumar B Mehta; Ana M Rodriguez; Yong-Fang Kuo; Anne C Kirchhoff
Journal:  Cancer       Date:  2017-05-23       Impact factor: 6.860

7.  Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.

Authors:  Theresa H M Keegan; Raymon H Grogan; Helen M Parsons; Li Tao; Michael G White; Kenan Onel; Pamela L Horn-Ross
Journal:  Thyroid       Date:  2015-04-20       Impact factor: 6.568

8.  The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population.

Authors:  Jennifer L Beebe-Dimmer; Terrance L Albrecht; Tara E Baird; Julie J Ruterbusch; Theresa Hastert; Felicity W K Harper; Michael S Simon; Judith Abrams; Kendra L Schwartz; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-27       Impact factor: 4.254

Review 9.  Financial Hardships Experienced by Cancer Survivors: A Systematic Review.

Authors:  Cheryl K Altice; Matthew P Banegas; Reginald D Tucker-Seeley; K Robin Yabroff
Journal:  J Natl Cancer Inst       Date:  2016-10-20       Impact factor: 13.506

10.  Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).

Authors:  Jonas A de Souza; Bonnie J Yap; Kristen Wroblewski; Victoria Blinder; Fabiana S Araújo; Fay J Hlubocky; Lauren H Nicholas; Jeremy M O'Connor; Bruce Brockstein; Mark J Ratain; Christopher K Daugherty; David Cella
Journal:  Cancer       Date:  2016-10-07       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.